V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240013904 | 240012153 | 1.8 | 97.8 | Disease modification (D) | null | 2015-02-04 | Methotrexate intrathecal | null | null | 240030788 | METHOTREXATE INTRATHECAL |
| 240013905 | 240007732 | 1.75 | 68 | Neo-adjuvant (N) | 2015-12-06 | 2015-12-23 | Carboplatin AUC 2 - 5 | 02 | N | 240030803 | CARBOPLATIN |
| 240013906 | 240007733 | 1.71 | 76.9 | Curative (C) | 2015-12-01 | 2015-12-10 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240030813 | NOT MATCHED |
| 240013907 | 240016101 | null | 59.6 | Palliative (P) | 2016-06-26 | 2016-06-27 | Azacitidine | N | null | 240030823 | AZACITIDINE |
| 240013908 | 240007738 | 1.68 | 78.2 | Curative (C) | 2014-03-11 | 2014-03-31 | Methotrexate intrathecal | N | N | 240030825 | METHOTREXATE INTRATHECAL |
| 240013909 | 240014230 | 1.51 | 86 | null | 2013-10-29 | 2013-11-05 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 240030857 | PACLITAXEL |
| 240013910 | 240012160 | 1.69 | 70.8 | Palliative (P) | 2018-04-29 | 2018-05-06 | Carboplatin AUC 2 - 5 | Y | N | 240030876 | CARBOPLATIN |
| 240013911 | 240007743 | 0 | 92 | Disease modification (D) | 2014-08-03 | 2014-08-07 | Trial Unspecified | 2 | N | 240030885 | TRIAL |
| 240013912 | 240007745 | null | null | Disease modification (D) | 2015-06-07 | 2015-06-08 | Azacitidine | N | N | 240030905 | AZACITIDINE |
| 240013913 | 240012162 | 1.61 | null | Palliative (P) | 2014-03-31 | 2014-03-31 | Methotrexate intrathecal | N | N | 240030910 | METHOTREXATE INTRATHECAL |
| 240013914 | 240007747 | 1.78 | 69 | Disease modification (D) | 2018-03-26 | 2018-03-30 | SMILE | N | N | 240030914 | TRIAL |
| 240013915 | 240007749 | 1.8 | 70.5 | Adjuvant (A) | 2014-03-23 | 2014-04-22 | CHOP - 21 days | N | N | 240030920 | CHOP |
| 240013916 | 240014234 | 1.63 | 100 | Palliative (P) | 2013-10-07 | 2013-11-11 | Trial Unspecified | 01 | N | 240030925 | TRIAL |
| 240013918 | 240007752 | 1.69 | 93 | Unknown (U) | 2015-01-10 | 2015-01-10 | Azacitidine | 1 | N | 240030938 | AZACITIDINE |
| 240013919 | 240007754 | null | null | Neo-adjuvant (N) | null | 2018-03-27 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240030946 | NOT MATCHED |
| 240013920 | 240015823 | null | 100 | Palliative (P) | 2013-05-31 | 2013-06-03 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240030954 | NOT MATCHED |
| 240013921 | 240007755 | 1.61 | 63.3 | Palliative (P) | 2017-08-30 | 2017-09-01 | ALCL ALCL 99 Closed BM 1, 2 or 3 | null | Y | 240030978 | NOT MATCHED |
| 240013922 | 240012169 | 1.06 | 64 | Curative (C) | 2017-04-01 | 2017-04-08 | ALCL ALCL 99 Closed Pre Phase | N | N | 240030978 | NOT MATCHED |
| 240013923 | 240007757 | 1.92 | 80.2 | Neo-adjuvant (N) | 2015-05-16 | 2015-05-29 | PACLITAXEL | N | N | 240030987 | PACLITAXEL |
| 240013924 | 240012170 | 1.73 | 81.9 | Palliative (P) | 2014-11-24 | 2014-12-30 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030989 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013925 | 240012171 | 1.62 | 108 | Palliative (P) | 2018-12-04 | 2018-12-05 | Paclitaxel 7 day | N | N | 240030991 | PACLITAXEL |
| 240013926 | 240012172 | 1.66 | 76.2 | Curative (C) | 2017-09-06 | 2017-09-26 | Trial Unspecified | 01 | N | 240030993 | TRIAL |
| 240013927 | 240007760 | 1.58 | 23.4 | Palliative (P) | null | 2018-03-28 | Bevacizumab | N | N | 240030997 | BEVACIZUMAB |
| 240013928 | 240007761 | 1.88 | null | Curative (C) | null | 2018-08-03 | Methotrexate intrathecal | 02 | N | 240031000 | METHOTREXATE INTRATHECAL |
| 240013929 | 240007762 | null | 59.7 | Palliative (P) | 2015-01-29 | 2015-01-29 | Bevacizumab 7.5mg/kg | 02 | N | 240031013 | BEVACIZUMAB |
| 240013930 | 240007763 | 1.8 | 58 | null | 2017-08-30 | 2017-08-30 | CHOP - 21 days | 02 | N | 240031031 | CHOP |
| 240013931 | 240007763 | 1.64 | 81 | null | 2018-05-19 | 2018-07-12 | PACLITAXEL | N | N | 240031031 | PACLITAXEL |
| 240013932 | 240012176 | null | 79.7 | null | 2015-01-06 | 2015-01-12 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 02 | N | 240031064 | NOT MATCHED |
| 240013933 | 240007768 | null | null | Curative (C) | 2015-01-04 | 2015-01-26 | INTERLACE TRIAL | N | N | 240031068 | INTERLACE TRIAL |
| 240013934 | 240007771 | 1.62 | 62.2 | Palliative (P) | 2013-09-22 | 2013-09-29 | Trial Unspecified | N | N | 240031088 | TRIAL |
| 240013935 | 240007772 | 1.73 | null | Neo-adjuvant (N) | 2016-09-17 | 2016-09-22 | Trial Unspecified | N | N | 240031088 | TRIAL |
| 240013936 | 240012180 | 1.83 | 79.5 | null | 2019-07-03 | 2019-07-03 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240031101 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013937 | 240007777 | 1.64 | 82.7 | null | 2018-05-14 | 2018-05-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | 240031104 | PACLITAXEL |
| 240013938 | 240007780 | 0 | 70.45 | Palliative (P) | null | 2017-10-12 | Trial Unspecified | Y | N | 240031114 | TRIAL |
| 240013939 | 240007782 | 1.74 | 35 | Palliative (P) | 2017-11-18 | 2017-11-19 | Trial Unspecified | 02 | N | 240031117 | TRIAL |
| 240013940 | 240014248 | 1.71 | 67 | null | 2016-08-01 | 2016-12-19 | INTERLACE TRIAL | 02 | N | 240031129 | INTERLACE TRIAL |
| 240013941 | 240007784 | null | 86 | Disease modification (D) | null | 2015-05-19 | Carboplatin AUC 2 - 5 | N | N | 240031131 | CARBOPLATIN |
| 240013942 | 240007793 | null | null | Palliative (P) | 2014-10-14 | 2015-02-16 | CARBOPLATIN | 2 | N | 240031190 | CARBOPLATIN |
| 240013943 | 240007797 | 0 | 36.8 | Not known (9) | 2017-06-13 | 2017-07-29 | Trial Unspecified | N | N | 240031218 | TRIAL |
| 240013944 | 240012188 | 1.6 | null | null | 2018-08-14 | 2018-08-14 | CHOP - 21 days | 2 | N | 240031227 | CHOP |
| 240013945 | 240007803 | null | null | Curative (C) | 2013-11-19 | 2013-11-19 | null | N | null | 240031242 | NOT MATCHED |
| 240013946 | 240015298 | 0 | 49 | Curative (C) | 2014-12-10 | 2014-12-11 | Trial Unspecified | 2 | N | 240031247 | TRIAL |
| 240013947 | 240007808 | 1.8 | 62.8 | Curative (C) | 2017-10-10 | 2017-10-30 | INTERLACE TRIAL | N | N | 240031262 | INTERLACE TRIAL |
| 240013948 | 240012192 | 0 | 97.8 | Curative (C) | 2018-03-07 | 2018-03-16 | INTERLACE TRIAL | N | N | 240031273 | INTERLACE TRIAL |
| 240013949 | 240012193 | 0 | 81 | Curative (C) | 2018-11-09 | 2018-11-09 | INTERLACE TRIAL | Y | N | 240031288 | INTERLACE TRIAL |
| 240013950 | 240015299 | null | 58.9 | Palliative (P) | 2015-06-10 | 2015-07-16 | Bevacizumab | 02 | N | 240031291 | BEVACIZUMAB |
| 240013951 | 240012196 | 1.63 | 54 | Unknown (U) | null | 2016-07-09 | Azacitidine | N | N | 240031305 | AZACITIDINE |
| 240013952 | 240007820 | null | null | Curative (C) | 2017-11-09 | 2017-11-17 | CHOP | N | N | 240031312 | CHOP |
| 240013953 | 240012197 | 1.67 | null | Disease modification (D) | 2015-07-31 | 2015-08-11 | Azacitidine | 01 | N | 240031315 | AZACITIDINE |
| 240013954 | 240007823 | 1.67 | 80.1 | Curative (C) | 2013-06-15 | 2013-07-08 | INTERLACE TRIAL | N | N | 240031325 | INTERLACE TRIAL |